Advancing gastrointestinal stromal tumor management: The role of imagomics features in precision risk assessment

Table 1 Clinical and pathological data of the low-risk group and the high-risk group, n (%)

	Low-risk group (n = 80)	High-risk group (n = 52)	P value
Age (years)	58.2 ± 13.1	68.6 ± 10.0	< 0.001
Gender			0.482
Female	44 (55.0)	24 (46.2)
Male	36 (45.0)	28 (53.8)
Maximal longitudinal diameter (cm)	5.8 ± 2.5	10.2 ± 2.8	< 0.001
The position of the tumor			0.270
Stomach	48 (60.0)	24 (46.2)
Gastric extracorporeal	32 (40.0)	28 (53.8)
Mitotic figures in pathology (50/HPF)			< 0.001
≤ 5	72 (90.0)	10 (23.8)
> 5	8 (10.0)	42 (76.2)

HPF: High power field.